Back to search

Article

Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells

2023-04-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Glioblastoma (GBM) is recognized as among the most aggressive forms of brain tumor. Patients typically present with a five-year survival rate of less than 6% with traditional surgery and chemoradiotherapy, which calls for novel immunotherapies like chimeric antigen receptor T (CAR-T) cells therapy. In response to endoplasmic reticulum (ER) stress in multiple tum...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8efa851-2289-5420-964f-02945fb373cb
DOI
10.21203/rs.3.rs-2775142/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cellsDOI 10.21203/rs.3.rs-2775142/v1
Select a neighboring publication to make it the new centre.